Therapeutic Asset Ratings
271 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Rintatolimod
Colorectal Cancer
Roswell Park Cancer Institute
P2
CC
(47)
2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A
Malignant Mesothelioma
Roswell Park Cancer Institute
P1
CC
(47)
2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A
Pleural Disorder
Roswell Park Cancer Institute
P1
CC
(47)
Photofrin II
Malignant Mesothelioma
Roswell Park Cancer Institute
P1
CC
(47)
Photofrin II
Pleural Disorder
Roswell Park Cancer Institute
P1
CC
(47)
5-ala
Colorectal Carcinoma
Roswell Park Cancer Institute
P1/2
CC
(47)
5-ala
Colorectal Cancer
Roswell Park Cancer Institute
P1/2
CC
(47)
Montanide Isa 51
Non-Small Cell Squamous Lung Carcinoma
Roswell Park Cancer Institute
P1/2
CC
(47)
Montanide Isa 51
PD-L1 Positive
Roswell Park Cancer Institute
P1/2
CC
(47)
Nivolumab
PD-L1 Positive
Roswell Park Cancer Institute
P1/2
CC
(47)
Pegcetacoplan
Malignant Pancreatic Neoplasm
Roswell Park Cancer Institute
P1/2
CC
(47)
Recombinant Human EGF-rP64K
Non-Small Cell Squamous Lung Carcinoma
Roswell Park Cancer Institute
P1/2
CC
(47)
Recombinant Human EGF-rP64K
PD-L1 Positive
Roswell Park Cancer Institute
P1/2
CC
(47)
INTERFERON ALFA-2B
Prostate Cancer
Roswell Park Cancer Institute
P2
CC
(46)
Decitabine
Advanced Malignant Solid Neoplasm
Roswell Park Cancer Institute
P1/2
CC
(45)
Decitabine
Cutaneous Melanoma
Roswell Park Cancer Institute
P1/2
CC
(45)
Interferon Alpha-2
Breast Cancer
Roswell Park Cancer Institute
P1/2
CC
(45)
Interferon Alpha-2
Triple-Negative Breast Carcinoma
Roswell Park Cancer Institute
P1/2
CC
(45)
Pegcetacoplan
Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute
P1/2
CC
(45)
Verteporfin
Cancer
Roswell Park Cancer Institute
P1/2
CC
(45)
Cediranib
Esophageal Carcinoma
Roswell Park Cancer Institute
P1
CC
(44)
Autologous Anti-Cd83 Car T-Cells
Acute Myeloid Leukemia
Roswell Park Cancer Institute
P1
CC
(43)
Carfilzomib
CD20 Positive
Roswell Park Cancer Institute
P1
CC
(43)
Cedazuridine
Prostate Cancer
Roswell Park Cancer Institute
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Showing 201 to 225 of 271 assets
Previous
Page 9 of 11
Next